| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bd18a5598892dad53b23cbfac6738a3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2005-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2009-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2dd29ea0e95114c89e8c66f27127f9b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c901b28e2f8307fc4b261feacfc2d70b |
| publicationDate |
2009-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2371198-C2 |
| titleOfInvention |
Improved supporting therapy of tumours expressing g250 |
| abstract |
FIELD: medicine. n SUBSTANCE: invention concerns medicine, particularly oncology, and can be applied in treatment of tumours expressing G250 antigen. Manufacturing of medicine for supporting therapy in case of non-metastatic disease after dissection of primary tumour expressing G250 antigen involves G-250-specific antibody and/or antibody fragment. n EFFECT: reduced risk of tumour recurrence due to cell cytotoxicity dependent on given antibody. n 18 cl, 4 tbl, 1 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2442983-C1 |
| priorityDate |
2004-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |